Dashboard
Aaron Elliott, Ph.D.
Chief Executive Officer

Dr. Elliott joined Ambry Genetics in 2008 as a laboratory scientist, working closely on the development of complex molecular diagnostic tests. During his years with the company, Dr. Elliott has held many leadership positions, including Director of Genomic Services, Vice President of Research and Development (R&D), and Chief Scientific Officer. As a member of the Executive Team, he plays a critical role in product development, quality control, and R&D planning.

Dr. Elliott began his career as a Postdoctoral Fellow at the Novartis Institute of Functional Genomics in San Diego, where he conducted research on potential drug targets for chemotherapeutic resistance and tumor formation. As part of this research, Dr. Elliott helped in identifying the first mitochondrial ABC transporter in cancer cells, which are responsible for multi-drug resistance in many solid tumors.

A graduate of Franklin and Marshall College, Dr. Elliott conducted his Ph.D. Genetics training at Thomas Jefferson University and The Johns Hopkins University School of Medicine. His thesis involved studying the role of CREB-binding protein in germline and stem cell development.